---
title: "Cigna (CI) Stock Could Be Cheap As Shares Drop 4%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306371750.md"
description: "Cigna Group's stock dropped 4.32% on Nov 19, 2026, trading around $270 with a market cap of ~$72.15b. The P/E ratio stands at 11.9x, significantly below the Healthcare sector average of 25.0x and peer group average of 26.6x. This valuation suggests the stock is undervalued relative to earnings, with analysts consensus indicating it may be 20% undervalued if the company successfully transitions to its Signature rebate-free PBM model while maintaining specialty earnings and customer retention."
datetime: "2026-11-21T15:17:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306371750.md)
  - [en](https://longbridge.com/en/news/306371750.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306371750.md)
generator: "portal-rs"
---

# Cigna (CI) Stock Could Be Cheap As Shares Drop 4%

Cigna Group has slipped in recent weeks after a sharp one day drop on 19 November 2026, and that pullback puts a fresh spotlight on whether the current share price around US$270 is still aligned with what the insurer actually earns. With the stock giving back some ground, the core issue for you is how much of Cigna Group's profit power is already baked into that valuation.

-   Over the past 5 years, Cigna Group has returned 47.2%, which makes the question of what investors are now paying for its earnings especially important.
-   The recent slide that took the stock down 4.32% on 19 November 2026, leaving the company valued near US$72.15b, can influence how the market is weighing its ability to keep turning those earnings into cash over time.
-   Your read on Cigna Group is one view; the desks covering it have another. See what analysts think Cigna Group's shares could be worth.

The issue now is whether Cigna Group's current share price is justified by its earnings when set against the Fair Ratio benchmark.

If you are weighing Cigna Group's recent pullback against what you are paying for its earnings, it can help to compare that trade off with companies in 40 high quality undervalued stocks

### Is Cigna Group Still Cheap on Earnings?

The P/E ratio suits Cigna Group because earnings remain the key anchor for a mature insurer. At roughly 11.9x, the stock changes hands at less than half the Healthcare sector average of about 25.0x and well below the peer group on roughly 26.6x. Against the Fair Ratio benchmark, which reflects what investors might usually pay for a business with Cigna Group's earnings profile and risk mix, the current multiple sits on the cheaper side, which signals that the market is pricing those profits cautiously.

Because the 4.32% drop on 19 November 2026 dragged the share price down without an accompanying change in the published earnings multiple, that slide leaves Cigna Group looking even more discounted on this earnings yardstick. For anyone weighing the recent pullback, the key question is whether the current 11.9x P/E simply reflects concern about future profit resilience or whether it points to a gap between what the insurer earns and what the market is currently willing to pay for those earnings. Explore the numbers behind Cigna Group's P/E valuation.

### The Cigna Group Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Cigna Group pick up where the P/E puzzle leaves off by spelling out which assumptions about growth, profitability and earnings would need to hold for the stock to be worth materially more or less than today’s price. Each one treats Cigna Group's estimated fair value as a thesis you can track over time, so you see how that story holds up as new information arrives, and they live on the company's Community page.

**One of the top narratives on Cigna Group: 20% undervalued**

This Narrative is the analyst consensus Narrative on Simply Wall St, which compiles analysts' consensus price target and revenue and earnings forecasts, not one person's view.

> *"The main requirement for this narrative is that Cigna successfully transitions clients to the Signature rebate-free PBM model while keeping specialty earnings, medical cost trends, and customer retention aligned with current expectations..."*

Discover why this Narrative puts Cigna Group at 20% undervalued.

### Cigna Group’s valuation is only one side of the decision

Before you decide how Cigna Group fits into your portfolio, it helps to know who is steering the business, how their incentives are set, and whether those rewards align with your outcomes. See who runs Cigna Group and how they are paid.

### Related Stocks

- [CI.US](https://longbridge.com/en/quote/CI.US.md)

## Related News & Research

- [Is Cigna Group (CI) Below Fair Value On Mixed Q3 2026 Earnings?](https://longbridge.com/en/news/305596810.md)
- [Bernstein Reaffirms Their Buy Rating on Cigna (CI)](https://longbridge.com/en/news/306105931.md)
- [Cigna beats Q3 adjusted revenue on segment growth, raises FY outlook](https://longbridge.com/en/news/304439506.md)
- [Elizabeth Warren Targets CVS, UnitedHealth and Cigna, Says Healthcare Giants ‘Take a Cut at Every Step’ as She Calls for Breaking Up Conglomerates](https://longbridge.com/en/news/305798081.md)
- [Hanil Feed's (KOSDAQ:005860) Conservative Accounting Might Explain Soft Earnings](https://longbridge.com/en/news/306378716.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**